Don’t mix your statins with grapefruit, or leafy green vegetables with warfarin.
Articles on Medicines
Displaying 81 - 100 of 140 articles
The EU is asking Australia to extend drug company monopolies. This could mean Australians wait longer for access to cheaper, generic medicines.
Could issues like price manipulation and over-regulation be having an impact on the medicine supply chain?
The cost of a life-saving drug in Canada is rising by 3,000 per cent. A national pharmacare plan could bring order to this chaotic world of Canadian drug prices.
Before travelling, plan ahead in case you need to pack medicines for sleep, diarrhoea, malaria, pain or anxiety.
There’s a common, popular and well-studied method to ensure new technologies are safe and effective for public use – even if researchers don’t fully understand how they work.
Researchers use an algorithm designed to help robots move to figure out what’s possible when designing new molecules in a promising class of pharmaceuticals.
If you look into your kitchen or bathroom cabinet, chances are you’d find some unused medicine, much of it expired. Here’s what to do with it.
People with type 2 diabetes are putting their health at risk by not taking their medication because of side effects.
Prescribing a drug for a condition it hasn’t been tested for may sound reckless, but off-label prescribing has a useful function in medicine.
Medication usage has gone through the roof in the last decade.
Canada is the only nation with a broad public health system lacking universal coverage for pharmaceuticals. Despite fears that pharmacare would be too costly, it could end up saving Canadians money.
Wider availability of the cystic fibrosis drug Kalydeco since May 1, 2017 means younger patients can now access it.
We have barely begun to tap into the pharmaceutical potential of the most diverse animals of all.
Consumers can’t always be confident claims for complementary medicines stack up. Here’s how to foster truth in advertising.
Every day, more discount pharmacy stores and chains are opening and assaulting health-care consumers with the “we are cheaper” message.
The well-used drug clomipramine could target tumour cells and leave normal cells healthy – if scientists could get enough evidence for it.
All the guidelines recommend paracetamol for pain relief despite the lack of evidence for the drug’s effectiveness.
Many suspect Van Gogh suffered from foxglove extract overdose due to the yellow halos in his paintings and his portrait of his physician holding the plant.
How new medicines subsidised by individual nations in the EU is a complicated business.
Top contributors
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Lecturer Pharmacy Practice, University of Sydney
-
Associate Professor in Pharmacy Practice, Kingston University
-
Professor in Pharmaceutical Policy, School of Pharmacy and Charles Perkins Centre, University of Sydney
-
Professor of Public Health, La Trobe University
-
Pharmacist and PhD Candidate, University of Sydney
-
Director and Taylor Family Chair, Centre for the Business & Economics of Health, The University of Queensland
-
Associate Lecturer and Registered Pharmacist, University of Sydney
-
Associate professor, University of Sydney
-
Senior Lecturer, Pharmacy, Aston University
-
Associate Lecturer, Sydney Pharmacy School, University of Sydney
-
Lecturer - Women's Health; Pharmacology, School of Biomedical Sciences, The University of Western Australia
-
Purple House Medical Advisor. Honorary ANU., Australian National University
-
Senior lecturer, School of Pharmacy, University of Sydney
-
Clinical Associate Professor in Pharmacy, University of Canberra